Eastern and South-Eastern Asia vs North Macedonia: Percentage of bloodstream infection due to methicillin-resistant
Eastern and South-Eastern Asia
41.3%
in 2022
North Macedonia
53.8%
in 2022
Eastern and South-Eastern Asia rank
9th
North Macedonia rank
9th
Percentage of bloodstream infection due to methicillin-resistant over time
- Eastern and South-Eastern Asia
- North Macedonia
How they compare
North Macedonia currently reports 53.8% against 41.3% in Eastern and South-Eastern Asia, a difference of 12.5%.
That makes North Macedonia's figure about 1.3 times Eastern and South-Eastern Asia's.
Across all 6 years both countries report, North Macedonia has been ahead every year.
Eastern and South-Eastern Asia ranks 9th and North Macedonia ranks 9th of 15 groups.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eastern and South-Eastern Asia | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 32.9% | 51.0% | 18.0% | North Macedonia |
| 2020s | 37.5% | 78.2% | 40.7% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Eastern and South-Eastern Asia or North Macedonia?
- North Macedonia, at 53.8% against 41.3% in Eastern and South-Eastern Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Eastern and South-Eastern Asia and North Macedonia?
- 12.5%, with North Macedonia ahead.
- How many years of comparable data are there for Eastern and South-Eastern Asia and North Macedonia?
- 6 years are reported by both, from 2017 to 2022.
- How do Eastern and South-Eastern Asia and North Macedonia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Eastern and South-Eastern Asia ranks 9th and North Macedonia ranks 9th of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.